Dataset Information

Regional distribution and losses of end-of-life steel throughout multiple product life cycles-Insights from the global multiregional MaTrace model.

ABSTRACT: Substantial amounts of post-consumer scrap are exported to other regions or lost during recovery and remelting, and both export and losses pose a constraint to desires for having regionally closed material cycles. To quantify the challenges and trade-offs associated with closed-loop metal recycling, we looked at the material cycles from the perspective of a single material unit and trace a unit of material through several product life cycles. Focusing on steel, we used current process parameters, loss rates, and trade patterns of the steel cycle to study how steel that was originally contained in high quality applications such as machinery or vehicles with stringent purity requirements gets subsequently distributed across different regions and product groups such as building and construction with less stringent purity requirements. We applied MaTrace Global, a supply-driven multiregional model of steel flows coupled to a dynamic stock model of steel use. We found that, depending on region and product group, up to 95% of the steel consumed today will leave the use phase of that region until 2100, and that up to 50% can get lost in obsolete stocks, landfills, or slag piles until 2100. The high losses resulting from business-as-usual scrap recovery and recycling can be reduced, both by diverting postconsumer scrap into long-lived applications such as buildings and by improving the recovery rates in the waste management and remelting industries. Because the lifetimes of high-quality (cold-rolled) steel applications are shorter and remelting occurs more often than for buildings and infrastructure, we found and quantified a tradeoff between low losses and high-quality applications in the steel cycle. Furthermore, we found that with current trade patterns, reduced overall losses will lead to higher fractions of secondary steel being exported to other regions. Current loss rates, product lifetimes, and trade patterns impede the closure of the steel cycle.

SUBMITTER: Pauliuk S

PROVIDER: S-EPMC5302007 | biostudies-other | 2017 Jan

REPOSITORIES: biostudies-other

ACCESS DATA

Publications

Regional distribution and losses of end-of-life steel throughout multiple product life cycles-Insights from the global multiregional MaTrace model.

Pauliuk Stefan S Kondo Yasushi Y Nakamura Shinichiro S Nakajima Kenichi K

Resources, conservation, and recycling 20170101

Substantial amounts of post-consumer scrap are exported to other regions or lost during recovery and remelting, and both export and losses pose a constraint to desires for having regionally closed material cycles. To quantify the challenges and trade-offs associated with closed-loop metal recycling, we looked at the material cycles from the perspective of a single material unit and trace a unit of material through several product life cycles. Focusing on steel, we used current process parameters ...[more]

PMID: 28216806

Similar Datasets

Project description:Study questionWhat variations underlie the menstrual cycle length and ovulation day of women trying to conceive?Summary answerBig data from a connected ovulation test revealed the extent of variation in menstrual cycle length and ovulation day in women trying to conceive.What is known alreadyTiming intercourse to coincide with the fertile period of a woman maximises the chances of conception. The day of ovulation varies on an inter- and intra-individual level.Study design size durationA total of 32?595 women who had purchased a connected ovulation test system contributed 75?981 cycles for analysis. Day of ovulation was determined from the fertility test results. The connected home ovulation test system enables users to identify their fertile phase. The app benefits users by enabling them to understand their personal fertility information. During each menstrual cycle, users input their perceived cycle length into an accessory application, and data on hormone levels from the tests are uploaded to the application and stored in an anonymised cloud database. This study compared users' perceived cycle characteristics with actual cycle characteristics. The perceived and actual cycle length information was analysed to provide population ranges.Participants/materials setting methodsThis study analysed data from the at-home use of a commercially available connected home ovulation test by women across the USA and UK.Main results and the role of chanceOverall, 25.3% of users selected a 28-day cycle as their perceived cycle length; however, only 12.4% of users actually had a 28-day cycle. Most women (87%) had actual menstrual cycle lengths between 23 and 35 days, with a normal distribution centred on day 28, and over half of the users (52%) had cycles that varied by 5 days or more. There was a 10-day spread of observed ovulation days for a 28-day cycle, with the most common day of ovulation being Day 15. Similar variation was observed for all cycle lengths examined. For users who conducted a test on every day requested by the app, a luteinising hormone (LH) surge was detected in 97.9% of cycles.Limitations reasons for cautionData were from a self-selected population of women who were prepared to purchase a commercially available product to aid conception and so may not fully represent the wider population. No corresponding demographic data were collected with the cycle information.Wider implications of the findingsUsing big data has provided more personalised insights into women's fertility; this could enable women trying to conceive to better time intercourse, increasing the likelihood of conception.Study funding/competing interestsThe study was funded by SPD Development Company Ltd (Bedford, UK), a fully owned subsidiary of SPD Swiss Precision Diagnostics GmbH (Geneva, Switzerland). I.S., B.G. and S.J. are employees of the SPD Development Company Ltd.

Project description:End-of-use and end-of-life medicines waste management has been a challenge for public and private managers in different countries. Reverse logistics is a waste management strategy whose application to public pharmaceutical care processes faces legal restrictions and incertitude. Nevertheless, reverse logistics of end-of-use and end-of-life medicines may be both a saving and an environmental strategy in developing countries that manage health under limited resources. How to overcome restrictions to reverse logistics mainly in the context of primary health level? This study aims to investigate the most relevant critical factors for implementing medicine waste management in pharmaceutical care process. The unit analysis is the primary health level process in a developing country capital. Considering the characteristics of the issue at hand, it was designed a qualitative study. Data was collected through semi-structured interviews. The interviewees were key individuals who work directly with the process-from administering medicine to patients to managing waste at the end of the medicine's lifespan or after its use. Results indicated that despite reverse logistics arising from end users is legally forbidden, another type of reverse flow emerged from process analysis. The reverse flow, named reassignment flow, consists of still useful end-of-use medicines exchanged among the 10 government-ran pharmacies and over 140 health centers, where healthcare professionals administer and offer guidance on how to use them correctly. Another result was the identification of the most critical factors in implementing reverse logistics strategies in the public management context. The factors mentioned included aspects pertaining to management, information technology, infrastructure, and government, but they differ from the private context management, in which decision-makers has more freedom. Due to the barriers named by interviewees, the political barriers and complexity of primary health system, results of this investigation point to (i) reinforcing the reassignment flows inside pharmaceutical care logistics cycle, for saving purposes, and (ii) further development of a specific management unit to perform reverse logistics of end-of-use medicines arising from consumers, for environmental purposes. In times of shortage or resources caused by the COVID-19 pandemic, to know the critical factors is a step necessary in overcoming the current restrictions in direction of a well-succeeded medicines reverse logistics, either of reassignment or from final consumers. These results clarify the literature on end-of-use and end-of-life medicines reverse logistics. It also provides managers of 5000 municipalities in the country a perspective on the most relevant critical factors involved in their decision-making process, concerning the reuse of end-of-use medicines or the adequate disposal of end-of-life medicines in the environment.

Dataset Information

Regional distribution and losses of end-of-life steel throughout multiple product life cycles-Insights from the global multiregional MaTrace model.

Publications

Regional distribution and losses of end-of-life steel throughout multiple product life cycles-Insights from the global multiregional MaTrace model.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets